Zai Lab Limited ADR (NASDAQ: ZLAB) kicked off on Friday, down -3.63% from the previous trading day, before settling in for the closing price of $32.50. Over the past 52 weeks, ZLAB has traded in a range of $16.01-$39.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 118.89%. While this was happening, its average annual earnings per share was recorded 44.55%. With a float of $108.40 million, this company’s outstanding shares have now reached $108.42 million.
The extent of productivity of a business whose workforce counts for 1869 workers is very important to gauge. In terms of profitability, gross margin is 63.45%, operating margin of -64.09%, and the pretax margin is -60.26%.
Zai Lab Limited ADR (ZLAB) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Zai Lab Limited ADR is 1.31%, while institutional ownership is 50.48%. The most recent insider transaction that took place on May 13 ’25, was worth 1,428,650. In this transaction Chairperson & CEO of this company sold 50,000 shares at a rate of $28.57, taking the stock ownership to the 479,851 shares. Before that another transaction happened on May 14 ’25, when Company’s Chairperson & CEO sold 46,389 for $28.09, making the entire transaction worth $1,302,857. This insider now owns 479,851 shares in total.
Zai Lab Limited ADR (ZLAB) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 44.55% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Take a look at Zai Lab Limited ADR’s (ZLAB) current performance indicators. Last quarter, stock had a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach 0.35 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
The latest stats from [Zai Lab Limited ADR, ZLAB] show that its last 5-days average volume of 0.82 million was inferior to 1.07 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 79.98%. Additionally, its Average True Range was 1.63.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 47.02%, which indicates a significant decrease from 66.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.63% in the past 14 days, which was lower than the 70.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.26, while its 200-day Moving Average is $27.66. Now, the first resistance to watch is $31.64. This is followed by the second major resistance level at $31.96. The third major resistance level sits at $32.35. If the price goes on to break the first support level at $30.93, it is likely to go to the next support level at $30.54. The third support level lies at $30.22 if the price breaches the second support level.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
The company with the Market Capitalisation of 3.44 billion has total of 110,328K Shares Outstanding. Its annual sales at the moment are 398,990 K in contrast with the sum of -257,100 K annual income. Company’s last quarter sales were recorded 106,490 K and last quarter income was -48,440 K.
